Skip to content

CODE B: what changed

BE 0542.536.242Other company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
-€605
2024 · -€605
Equity
€13,733
2024 · €14,338-€605
Cash
-
not filed
Balance sheet total
€15,866
2024 · €15,866

Largest movements

2024 to 2025
Assets

No asset line moved by more than 1% of the balance sheet total.

    Equity and liabilities
    • Profit (loss) carried forward -€605

      down €605 (-9.6%), from €6,278 to €5,673

    • Other debts +€605

      up €605 (+39.6%), from €1,528 to €2,133

    Income statement

    No income-statement line moved by more than 1% of the activity.

      Change in the result, 2024 to 2025

      effect on the result

      For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

      Result 2024 -€605
      Result 2025 -€605

      Derived cash bridge

      cash 2024 to 2025

      Cash or the result is not a separate line in both sets of accounts. So the cash flow cannot be derived from them.

      Every line side by side 19 lines
      Line Code 2024 2025 Change %
      Total assets 20/58 €15,866 €15,866 = 0.0%
      Current assets 29/58 €15,866 €15,866 = 0.0%
      Amounts receivable within one year 40/41 €15,866 €15,866 = 0.0%
      Trade receivables 40 €15,866 €15,866 = 0.0%
      Total equity and liabilities 10/49 €15,866 €15,866 = 0.0%
      Equity 10/15 €14,338 €13,733 -€605 -4.2%
      Contributions 10/11 €6,200 €6,200 = 0.0%
      Reserves 13 €1,860 €1,860 = 0.0%
      Non-distributable reserves 130/1 €1,860 €1,860 = 0.0%
      Reserves not available under the articles 1311 €1,860 €1,860 = 0.0%
      Profit (loss) carried forward 14 €6,278 €5,673 -€605 -9.6%
      Amounts payable 17/49 €1,528 €2,133 +€605 +39.6%
      Amounts payable within one year 42/48 €1,528 €2,133 +€605 +39.6%
      Other amounts payable 47/48 €1,528 €2,133 +€605 +39.6%
      Gross operating margin 9900 -€605 -€605 = 0.0%
      Operating profit (loss) 9901 -€605 -€605 = 0.0%
      Profit (loss) for the period before taxes 9903 -€605 -€605 = 0.0%
      Profit (loss) for the period 9904 -€605 -€605 = 0.0%
      Profit (loss) for the period to be appropriated 9905 -€605 -€605 = 0.0%

      Value

      latest balance sheet 31-12-2025 · indication, not a valuation or advice

      Indicative value of the equity

      Indication, not a valuation or advice
      €13,733 to €13,733

      Midpoint €13,733 · adjusted equity only

      Capitalisation rate 12% result over 3 years earnings weight 50%

      Adjusted equity €13,733
      Indication €13,733

      Adjusted equity

      balance sheet 31-12-2025
      Equity (10/15)
      €13,733
      Revaluation of assets
      €0
      Deferred tax on the revaluation
      €0
      Other adjustment
      €0
      Adjusted equity
      €13,733

      Capitalised earnings

      net result for the year (9904)
      2025
      -€605
      2024
      -€605
      2023
      -€605
      2022
      -€303
      2021
      -€804
      Average result
      -€605
      Divided by the capitalisation rate
      14% / 12% / 10%
      Capitalised earnings
      not meaningful, as the average result is zero or negative

      Limits of the indication

      • Checked holds no market prices or comparable transactions.
      • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
      • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
      • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

      For a valuation to base a decision on, go to a company auditor or a certified accountant.

      Calculation and sources

      Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 14 November 2026 via checked.be.